GPT Healthcare (NSE:GPTHEALTH) Current Deferred Revenue: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:GPTHEALTH GPT Healthcare Ltd NSE:GPTHEALTH
44 GF Score
Price ₹151.72
! 1 Warning Sign
View Full Analysis

What is GPT Healthcare Current Deferred Revenue?

GPT Healthcare NSE:GPTHEALTH +0.22% 44 Current Deferred Revenue is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:GPTHEALTH with a GF Score™ of 44/100. The stock has 1 warning sign investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

GPT Healthcare's current deferred revenue for the quarter that ended in Jun. 2026 was ₹0 Mil.

GPT Healthcare Current Deferred Revenue Related Terms

GPT Healthcare Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for GPT Healthcare's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GPT Healthcare Current Deferred Revenue Chart

GPT Healthcare Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Current Deferred Revenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

GPT Healthcare Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:GPTHEALTH
44GF Score
GPT Healthcare Ltd NSE:GPTHEALTH
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of ₹0 Mil mean?
GPT Healthcare (NSE:GPTHEALTH) has a Current Deferred Revenue of ₹0 Mil as of Jun. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on GPT Healthcare and its competitors.
Is GPT Healthcare's Current Deferred Revenue too high?
GPT Healthcare's current Current Deferred Revenue is ₹0 Mil. Overall, GPT Healthcare has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does GPT Healthcare's Current Deferred Revenue compare to HCA and THC?
GPT Healthcare's Current Deferred Revenue of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on GPT Healthcare and its competitors. GPT Healthcare's current Current Deferred Revenue is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GPT Healthcare stock overvalued right now?
GPT Healthcare (NSE:GPTHEALTH) has a current Current Deferred Revenue of ₹0 Mil. The current Current Deferred Revenue is ₹0 Mil. GPT Healthcare's overall GF Score™ is 44/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For GPT Healthcare (NSE:GPTHEALTH), the current Current Deferred Revenue is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GPT Healthcare Business Description

Other Exchanges 544131:India
Address Sector III, GPT Centre, JC-25, Salt Lake, Kolkata, WB, IND, 700106
GPT Healthcare Ltd is engaged in the healthcare sector. It operates a chain of mid-sized full-service hospitals under the ILS brand. It provides integrated healthcare services, with a focus on secondary and tertiary care and operates four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of approximately 561 beds. It offers a comprehensive range of healthcare services across over 35 specialities and super specialities, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.
44GF Score

Get the complete analysis for NSE:GPTHEALTH

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹151.72
Price